Stifel initiated coverage on Apollo Medical with a new price target
$AMEH
Professional Services
Consumer Discretionary
Stifel initiated coverage of Apollo Medical with a rating of Buy and set a new price target of $45.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/22/2024 | $44.00 → $55.00 | Neutral → Buy | BofA Securities |
| 1/24/2024 | $45.00 | Buy | Stifel |
| 12/22/2023 | $41.00 | Hold | Truist |
| 10/17/2023 | $45.00 | Buy | BTIG Research |
| 4/12/2023 | $44.00 | Neutral | BofA Securities |
| 12/19/2022 | $40.00 | Buy | Lake Street |
| 9/21/2022 | Outperform | William Blair | |
| 1/11/2022 | $93.00 | Buy | Colliers Securities |
BofA Securities upgraded Apollo Medical from Neutral to Buy and set a new price target of $55.00 from $44.00 previously
Stifel initiated coverage of Apollo Medical with a rating of Buy and set a new price target of $45.00
Truist initiated coverage of Apollo Medical with a rating of Hold and set a new price target of $41.00
ALHAMBRA, Calif., Feb. 22, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, announced today it will formally change its name from Apollo Medical Holdings, Inc. ("ApolloMed") to Astrana Health, Inc. ("Astrana Health"). As previously announced, the Company will begin trading under the ticker symbol "ASTH." Both changes will take effect February 26, 2024.
ALHAMBRA, Calif., Jan. 31, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2023, after the close of the stock market on Tuesday, February 27, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.
ALHAMBRA, Calif., Jan. 29, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced a strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. The partnership will bolster BASS Medical Group's value-based care and operational infra